Medicine information CABOZANTINIB TERAPIA 20mg film-coated tablets

Product code:
W72253001
Quantity:
30
Indicated for:
renal cell carcinoma; hepatocellular carcinoma; thyroid cancer
Route of administration:
oral
Substance:
cabozantinib (antineoplastic agent)
ATC
L01EX07 — Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors
Cabozantinib is a medication used for the treatment of certain types of cancer, including advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. It is a tyrosine kinase inhibitor that blocks multiple signaling pathways involved in tumor growth, angiogenesis, and metastasis.

The medication is taken orally, usually once daily, as directed by a doctor. The dosage may be adjusted based on the patient's response and treatment tolerability.

Common side effects include diarrhea, nausea, fatigue, loss of appetite, high blood pressure, and changes in liver function. In rare cases, more severe adverse effects such as gastrointestinal perforations, severe bleeding, or reversible posterior leukoencephalopathy syndrome may occur.

Cabozantinib is not recommended for pregnant or breastfeeding women, as it may affect fetal development. Patients should inform their doctor about all medications they are taking to avoid drug interactions. Additionally, regular monitoring is important to detect and manage potential adverse effects.

General data about CABOZANTINIB TERAPIA 20mg

Substance:
cabozantinib
Date of latest medicines list:
01-11-2026
Product code:
W72253001
Strength:
20mg
Pharmaceutical form:
film-coated tablets
Quantity:
30
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
TERAPIA S.A - ROMANIA
Holder:
TERAPIA S.A. - ROMANIA
Number:
16915/2026/01
Shelf life:
2 years

Strengths available for cabozantinib

  • 20mg
  • 40mg
  • 60mg

Warnings:

Fertility warning

This medicine may affect fertility.

Dose adjustment in hepatic impairment

Dose adjustment may be needed in liver disease.

Cytotoxic / special handling

Handle with special care.

Contraception required

Effective contraception is required during treatment.

Contraindicated during breastfeeding

Do not use this medicine while breastfeeding.

Contraindicated during pregnancy

Do not use this medicine during pregnancy.

Avoid grapefruit

Avoid grapefruit and grapefruit juice.

Hepatotoxicity

This medicine may affect the liver.

Major drug interactions

This medicine may have important interactions with other medicines.

Myelosuppression / agranulocytosis

This medicine may lower blood cell counts.

Additional monitoring

This medicine is subject to additional monitoring.

Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Severe skin reactions

Stop taking the medicine and seek urgent medical help if a severe rash occurs.